A novel hydrogel, CHITOXAN(TM) (CH-X), has po-tential as a vehicle for cont
rolled drug delivery. The hydrogel is obtained by complexation of two polys
accharides, chitosan and xanthan. In the present work we investigated the b
iocompatibility of the complex using in vitro and in vivo models. The cytot
oxic effects of CH-X microspheres as well as their degradation products at
different concentrations were assessed on fibroblasts (fibroblast cell line
L-929) using 3-(4,5-dimethylthiazole-2yl)-2,5-triphenyl tetrazolium) (MTT)
. The test is based on mitochondrial dehydrogenase cell activity as an indi
cator of cell viability. Interleukin-1 beta (IL-1 beta) and tumor necrosis
factor-alpha (TNF-alpha) cytokines as well as nitric oxide (NO) production
by macrophages (macrophage cell line J-774) were examined as indicators of
cell activation. In vivo biocompatibility assessment was performed for 1 to
12 weeks. This study was performed using tablets obtained after compressio
n of CH-X particles implanted at the subcutaneous level in male Wistar rats
. CH-X biocompatibility and degradation were investigated using histologica
l studies. Light and transmission electron microscopy (TEM) analyses were u
sed to determine the foreign-body reaction and phagocytosis of the implants
by macrophages. Fibroblast exposition to CH-X particles and degradation pr
oducts did not show cytotoxic effects as measured by MTT test. TNF-alpha pr
oduction was dependent on CH-X particles concentration, whereas IL-1 beta p
roduction was found to be dose independent. CH-X extract products stimulate
d TNF-alpha secretion when used at the highest concentration (10 mg/mL), no
tably after 28 days' degradation time. No effect was observed on IL-1 beta
production when CH-X extracts were used in comparison to the control. The e
ffects of CH-X particles on NO secretion were similar as on TNF-alpha. Hist
ological studies showed that CH-X tablets broke down into particles which p
rogressively degraded into smaller fragments. A significant fraction of the
fragments was ingested by the macrophages after 12 weeks of implantation.
Light microscopy studies showed a weak foreign-body reaction as a function
of time and the fibrous layer thickness decreased with time of implantation
. (C) 2000 John Wiley & Sons, Inc. J Biomed Mater Res, 51, 107-116, 2000.